Ankyloblepharon and Luseogliflozin: Difference between pages

From WikiMD.org
(Difference between pages)
Jump to navigation Jump to search
(CSV import)
 
(CSV import)
 
Line 1: Line 1:
== Ankyloblepharon ==
'''Luseogliflozin''' (pronounced loo-see-oh-gli-floh-zin) is a type of [[antidiabetic drug]] specifically classified as a [[Sodium-glucose cotransporter 2 inhibitors|Sodium-glucose cotransporter 2 (SGLT2) inhibitor]]. It is used in the treatment of [[Type 2 diabetes]].


'''Ankyloblepharon''' (pronounced: an-ky-lo-blef-a-ron) is a rare medical condition characterized by the partial or complete fusion of the eyelids. The term is derived from the Greek words "ankylos" meaning fused and "blepharon" meaning eyelid.
==Etymology==
The name "Luseogliflozin" is derived from the class of drugs it belongs to, the SGLT2 inhibitors. The "-gliflozin" suffix is common to all drugs in this class.


== Etymology ==
==Pharmacology==
Luseogliflozin works by inhibiting the SGLT2 protein, which is responsible for reabsorbing glucose in the kidneys. By inhibiting this protein, Luseogliflozin causes excess glucose to be excreted in the urine, thereby lowering blood glucose levels.


The term Ankyloblepharon is derived from two Greek words. "Ankylos" which means fused or bound, and "blepharon" which refers to the eyelid. Thus, the term literally translates to "fused eyelids".
==Related Terms==
* [[Sodium-glucose cotransporter 2 inhibitors|SGLT2 inhibitors]]
* [[Type 2 diabetes]]
* [[Antidiabetic drug]]
* [[Glucose]]
* [[Kidneys]]


== Symptoms ==
==See Also==
* [[Canagliflozin]]
* [[Dapagliflozin]]
* [[Empagliflozin]]


The primary symptom of Ankyloblepharon is the partial or complete fusion of the eyelids. This can lead to a range of visual impairments, including [[Blindness|blindness]] and [[Strabismus|strabismus]]. Other symptoms may include [[Photophobia|photophobia]] (sensitivity to light), [[Epiphora|epiphora]] (excessive tearing), and [[Blepharitis|blepharitis]] (inflammation of the eyelids).
[[Category:Medicine]]
[[Category:Pharmacology]]
[[Category:Diabetes]]


== Causes ==
Ankyloblepharon can be caused by a variety of factors, including genetic disorders such as [[Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) Syndrome|AEC Syndrome]] and [[Hay-Wells syndrome|Hay-Wells syndrome]]. It can also be caused by trauma to the eye, such as burns or chemical injuries.
== Treatment ==
Treatment for Ankyloblepharon typically involves surgical separation of the fused eyelids. This is usually performed by an [[Ophthalmologist|ophthalmologist]] and may involve the use of skin grafts. In some cases, additional treatments may be necessary to address underlying conditions or complications.
== See also ==
* [[Blepharophimosis]]
* [[Cryptophthalmos]]
* [[Anophthalmia]]
== References ==
== External links ==
[[Category:Eye diseases]]
[[Category:Rare diseases]]
[[Category:Genetic disorders]]
{{dictionary-stub}}
{{dictionary-stub}}

Latest revision as of 22:33, 7 February 2024

Luseogliflozin (pronounced loo-see-oh-gli-floh-zin) is a type of antidiabetic drug specifically classified as a Sodium-glucose cotransporter 2 (SGLT2) inhibitor. It is used in the treatment of Type 2 diabetes.

Etymology

The name "Luseogliflozin" is derived from the class of drugs it belongs to, the SGLT2 inhibitors. The "-gliflozin" suffix is common to all drugs in this class.

Pharmacology

Luseogliflozin works by inhibiting the SGLT2 protein, which is responsible for reabsorbing glucose in the kidneys. By inhibiting this protein, Luseogliflozin causes excess glucose to be excreted in the urine, thereby lowering blood glucose levels.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Retrieved from "https://wikimd.org/w/index.php?title=Ankyloblepharon&oldid=1499249"